

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.25140337 |
| 2 | chaperone-mediated protein transport (GO:0072321) | 5.23602082 |
| 3 | pseudouridine synthesis (GO:0001522) | 4.94367074 |
| 4 | GDP-mannose metabolic process (GO:0019673) | 4.80287412 |
| 5 | ribosome biogenesis (GO:0042254) | 4.54481830 |
| 6 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.48606711 |
| 7 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 4.28971349 |
| 8 | protein-cofactor linkage (GO:0018065) | 4.22027647 |
| 9 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.09417578 |
| 10 | negative regulation of telomerase activity (GO:0051974) | 3.99909610 |
| 11 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.92908198 |
| 12 | proteasome assembly (GO:0043248) | 3.89458256 |
| 13 | spliceosomal snRNP assembly (GO:0000387) | 3.86606154 |
| 14 | negative regulation of B cell apoptotic process (GO:0002903) | 3.84379629 |
| 15 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.80404170 |
| 16 | transcription from mitochondrial promoter (GO:0006390) | 3.79149929 |
| 17 | ribosomal small subunit biogenesis (GO:0042274) | 3.68405430 |
| 18 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.66856047 |
| 19 | innate immune response in mucosa (GO:0002227) | 3.64735103 |
| 20 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.64372531 |
| 21 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.63526963 |
| 22 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.63526963 |
| 23 | ATP synthesis coupled proton transport (GO:0015986) | 3.60538374 |
| 24 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.60538374 |
| 25 | ribosomal small subunit assembly (GO:0000028) | 3.56048330 |
| 26 | tRNA modification (GO:0006400) | 3.55279017 |
| 27 | rRNA processing (GO:0006364) | 3.52230125 |
| 28 | protein targeting to mitochondrion (GO:0006626) | 3.49925103 |
| 29 | regulation of mitochondrial translation (GO:0070129) | 3.48418077 |
| 30 | establishment of protein localization to mitochondrion (GO:0072655) | 3.48278443 |
| 31 | viral mRNA export from host cell nucleus (GO:0046784) | 3.46775081 |
| 32 | termination of RNA polymerase III transcription (GO:0006386) | 3.46061365 |
| 33 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.46061365 |
| 34 | chromatin assembly (GO:0031497) | 3.45520806 |
| 35 | maturation of SSU-rRNA (GO:0030490) | 3.41671856 |
| 36 | rRNA metabolic process (GO:0016072) | 3.40845154 |
| 37 | inner mitochondrial membrane organization (GO:0007007) | 3.38735355 |
| 38 | cellular component biogenesis (GO:0044085) | 3.27601876 |
| 39 | 7-methylguanosine mRNA capping (GO:0006370) | 3.27574190 |
| 40 | protein K6-linked ubiquitination (GO:0085020) | 3.27082358 |
| 41 | protein deneddylation (GO:0000338) | 3.22816500 |
| 42 | proline biosynthetic process (GO:0006561) | 3.20702982 |
| 43 | RNA capping (GO:0036260) | 3.17360873 |
| 44 | 7-methylguanosine RNA capping (GO:0009452) | 3.17360873 |
| 45 | tRNA processing (GO:0008033) | 3.16943878 |
| 46 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.15394739 |
| 47 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.15164100 |
| 48 | mitochondrial RNA metabolic process (GO:0000959) | 3.13618521 |
| 49 | negative regulation of telomere maintenance (GO:0032205) | 3.11260168 |
| 50 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.09292906 |
| 51 | mucosal immune response (GO:0002385) | 3.08616919 |
| 52 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.04925156 |
| 53 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.03671372 |
| 54 | tRNA methylation (GO:0030488) | 3.03228742 |
| 55 | ncRNA processing (GO:0034470) | 3.02677517 |
| 56 | protein localization to mitochondrion (GO:0070585) | 3.02401340 |
| 57 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.00189157 |
| 58 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.96963352 |
| 59 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.96817091 |
| 60 | DNA strand elongation (GO:0022616) | 2.91748225 |
| 61 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.89425236 |
| 62 | ribosomal large subunit biogenesis (GO:0042273) | 2.89390007 |
| 63 | protein maturation by protein folding (GO:0022417) | 2.87739568 |
| 64 | tRNA metabolic process (GO:0006399) | 2.86827601 |
| 65 | antibacterial humoral response (GO:0019731) | 2.85014595 |
| 66 | regulation of translational termination (GO:0006449) | 2.84690981 |
| 67 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.84201076 |
| 68 | rRNA modification (GO:0000154) | 2.83491382 |
| 69 | ncRNA metabolic process (GO:0034660) | 2.82997340 |
| 70 | peptidyl-arginine methylation (GO:0018216) | 2.82749137 |
| 71 | peptidyl-arginine N-methylation (GO:0035246) | 2.82749137 |
| 72 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.82711711 |
| 73 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.82711711 |
| 74 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.81637104 |
| 75 | respiratory electron transport chain (GO:0022904) | 2.79326211 |
| 76 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.78527372 |
| 77 | positive regulation of viral transcription (GO:0050434) | 2.77608293 |
| 78 | translation (GO:0006412) | 2.77065615 |
| 79 | regulation of telomerase activity (GO:0051972) | 2.76574332 |
| 80 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.76233628 |
| 81 | translational elongation (GO:0006414) | 2.74809686 |
| 82 | electron transport chain (GO:0022900) | 2.74463136 |
| 83 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.74043124 |
| 84 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.73810862 |
| 85 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.73302677 |
| 86 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.72469210 |
| 87 | histone arginine methylation (GO:0034969) | 2.69158117 |
| 88 | protein localization to chromosome, centromeric region (GO:0071459) | 2.66458143 |
| 89 | nucleosome assembly (GO:0006334) | 2.65898137 |
| 90 | viral transcription (GO:0019083) | 2.64272824 |
| 91 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.63631817 |
| 92 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.63272782 |
| 93 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.63272782 |
| 94 | negative regulation of RNA splicing (GO:0033119) | 2.63206109 |
| 95 | metallo-sulfur cluster assembly (GO:0031163) | 2.63174207 |
| 96 | iron-sulfur cluster assembly (GO:0016226) | 2.63174207 |
| 97 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.62509304 |
| 98 | negative regulation of cell cycle arrest (GO:0071157) | 2.61673070 |
| 99 | de novo protein folding (GO:0006458) | 2.60680378 |
| 100 | de novo posttranslational protein folding (GO:0051084) | 2.60246611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.72156488 |
| 2 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.31822888 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.23725595 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.10756233 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.99794924 |
| 6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.89127030 |
| 7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84733147 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.83121161 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.80564209 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.73070387 |
| 11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.68843043 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.68321830 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.61571342 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.59789190 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.58938895 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.54358050 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.44595784 |
| 18 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.41963148 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.38843626 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.35068744 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.27608488 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.24074496 |
| 23 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.20296356 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.18578745 |
| 25 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.18329946 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.17483920 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.14974048 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.09216769 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.08127248 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.07851284 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.05347153 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.03225758 |
| 33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.01292132 |
| 34 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.94878352 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.92790710 |
| 36 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.89083438 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.87353981 |
| 38 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.86848126 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84897138 |
| 40 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.84041658 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84000557 |
| 42 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.83206483 |
| 43 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.80168036 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77385688 |
| 45 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.72863330 |
| 46 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.71881184 |
| 47 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.69776735 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67180922 |
| 49 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.66121663 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65844808 |
| 51 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.64563529 |
| 52 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.64086295 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63482547 |
| 54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.62509987 |
| 55 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58322949 |
| 56 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55881819 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50024020 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.48531668 |
| 59 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.46473002 |
| 60 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.45158283 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43497389 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40888747 |
| 63 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39237450 |
| 64 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34668372 |
| 65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.33276256 |
| 66 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.31696008 |
| 67 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30418323 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.29219480 |
| 69 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.26424193 |
| 70 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.26353793 |
| 71 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.26152412 |
| 72 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.21227343 |
| 73 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.16890985 |
| 74 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16044244 |
| 75 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14891608 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.13546898 |
| 77 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.10091096 |
| 78 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08767721 |
| 79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08530852 |
| 80 | MAF_26560356_Chip-Seq_TH1_Human | 1.07956431 |
| 81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07819415 |
| 82 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07333868 |
| 83 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06952109 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.06599981 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06132705 |
| 86 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.05801196 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05531404 |
| 88 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.05350477 |
| 89 | P68_20966046_ChIP-Seq_HELA_Human | 1.05121594 |
| 90 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03694986 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03308069 |
| 92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00246071 |
| 93 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.99024250 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96765146 |
| 95 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95897989 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95851838 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95527141 |
| 98 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.95281280 |
| 99 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94736908 |
| 100 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.94465432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003111_abnormal_nucleus_morphology | 4.23665471 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 4.05195104 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.66631488 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.18886558 |
| 5 | MP0001529_abnormal_vocalization | 3.14485774 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.13274094 |
| 7 | MP0008007_abnormal_cellular_replicative | 3.05887979 |
| 8 | MP0000685_abnormal_immune_system | 3.04573037 |
| 9 | MP0008058_abnormal_DNA_repair | 2.79419697 |
| 10 | MP0003077_abnormal_cell_cycle | 2.54344976 |
| 11 | MP0003786_premature_aging | 2.45956771 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.35670551 |
| 13 | MP0003950_abnormal_plasma_membrane | 2.33456700 |
| 14 | MP0009046_muscle_twitch | 2.22912489 |
| 15 | MP0005623_abnormal_meninges_morphology | 2.13799180 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.12216770 |
| 17 | MP0006035_abnormal_mitochondrial_morpho | 1.91213738 |
| 18 | MP0008932_abnormal_embryonic_tissue | 1.79435509 |
| 19 | MP0001727_abnormal_embryo_implantation | 1.78303842 |
| 20 | MP0005671_abnormal_response_to | 1.75840693 |
| 21 | MP0000358_abnormal_cell_content/ | 1.69299945 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.66804850 |
| 23 | MP0002254_reproductive_system_inflammat | 1.63535051 |
| 24 | MP0000350_abnormal_cell_proliferation | 1.63200035 |
| 25 | MP0000678_abnormal_parathyroid_gland | 1.61039410 |
| 26 | MP0005257_abnormal_intraocular_pressure | 1.56154458 |
| 27 | MP0002332_abnormal_exercise_endurance | 1.55120494 |
| 28 | MP0003718_maternal_effect | 1.51045210 |
| 29 | MP0005360_urolithiasis | 1.46040832 |
| 30 | MP0000049_abnormal_middle_ear | 1.40154381 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.38519378 |
| 32 | MP0001881_abnormal_mammary_gland | 1.38510179 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.36172373 |
| 34 | MP0002282_abnormal_trachea_morphology | 1.35976157 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.34879088 |
| 36 | MP0002160_abnormal_reproductive_system | 1.32521186 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.29533851 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.28358721 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.26150425 |
| 40 | MP0000313_abnormal_cell_death | 1.22066066 |
| 41 | MP0002019_abnormal_tumor_incidence | 1.21973646 |
| 42 | MP0000631_abnormal_neuroendocrine_gland | 1.20946548 |
| 43 | MP0001730_embryonic_growth_arrest | 1.15133960 |
| 44 | MP0009250_abnormal_appendicular_skeleto | 1.15005077 |
| 45 | MP0001873_stomach_inflammation | 1.14131147 |
| 46 | MP0003123_paternal_imprinting | 1.13308589 |
| 47 | MP0002398_abnormal_bone_marrow | 1.13038946 |
| 48 | MP0001661_extended_life_span | 1.12174001 |
| 49 | MP0001270_distended_abdomen | 1.11277251 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.10877925 |
| 51 | MP0004742_abnormal_vestibular_system | 1.10388519 |
| 52 | MP0002249_abnormal_larynx_morphology | 1.08692178 |
| 53 | MP0008057_abnormal_DNA_replication | 1.08213596 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.07056983 |
| 55 | MP0001879_abnormal_lymphatic_vessel | 1.05561440 |
| 56 | MP0004510_myositis | 1.04884979 |
| 57 | MP0002722_abnormal_immune_system | 1.04265555 |
| 58 | MP0004134_abnormal_chest_morphology | 1.02375536 |
| 59 | MP0005266_abnormal_metabolism | 1.01136501 |
| 60 | MP0001293_anophthalmia | 0.98834759 |
| 61 | MP0002210_abnormal_sex_determination | 0.98675061 |
| 62 | MP0005389_reproductive_system_phenotype | 0.97853596 |
| 63 | MP0001800_abnormal_humoral_immune | 0.97287988 |
| 64 | MP0002080_prenatal_lethality | 0.92788521 |
| 65 | MP0000490_abnormal_crypts_of | 0.91893078 |
| 66 | MP0002429_abnormal_blood_cell | 0.88768777 |
| 67 | MP0001919_abnormal_reproductive_system | 0.87656116 |
| 68 | MP0001790_abnormal_immune_system | 0.84749463 |
| 69 | MP0005387_immune_system_phenotype | 0.84749463 |
| 70 | MP0000750_abnormal_muscle_regeneration | 0.84392883 |
| 71 | MP0003942_abnormal_urinary_system | 0.83973948 |
| 72 | MP0001697_abnormal_embryo_size | 0.83215930 |
| 73 | MP0000689_abnormal_spleen_morphology | 0.82837733 |
| 74 | MP0002006_tumorigenesis | 0.82762997 |
| 75 | MP0000716_abnormal_immune_system | 0.81543026 |
| 76 | MP0000733_abnormal_muscle_development | 0.79516514 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.78647353 |
| 78 | MP0002177_abnormal_outer_ear | 0.77400611 |
| 79 | MP0003186_abnormal_redox_activity | 0.76936225 |
| 80 | MP0005499_abnormal_olfactory_system | 0.75408810 |
| 81 | MP0005394_taste/olfaction_phenotype | 0.75408810 |
| 82 | MP0010030_abnormal_orbit_morphology | 0.74111694 |
| 83 | MP0003984_embryonic_growth_retardation | 0.72297158 |
| 84 | MP0003315_abnormal_perineum_morphology | 0.71290783 |
| 85 | MP0008995_early_reproductive_senescence | 0.71196566 |
| 86 | MP0001905_abnormal_dopamine_level | 0.70412647 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.70233721 |
| 88 | MP0005000_abnormal_immune_tolerance | 0.70179310 |
| 89 | MP0000749_muscle_degeneration | 0.69527032 |
| 90 | MP0005384_cellular_phenotype | 0.69454467 |
| 91 | MP0001764_abnormal_homeostasis | 0.68016965 |
| 92 | MP0000026_abnormal_inner_ear | 0.67548336 |
| 93 | MP0002723_abnormal_immune_serum | 0.66494173 |
| 94 | MP0001672_abnormal_embryogenesis/_devel | 0.66082840 |
| 95 | MP0005380_embryogenesis_phenotype | 0.66082840 |
| 96 | MP0002088_abnormal_embryonic_growth/wei | 0.65562570 |
| 97 | MP0008789_abnormal_olfactory_epithelium | 0.65221935 |
| 98 | MP0002653_abnormal_ependyma_morphology | 0.64014843 |
| 99 | MP0000747_muscle_weakness | 0.61932695 |
| 100 | MP0002420_abnormal_adaptive_immunity | 0.61544067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 4.51439096 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.89181894 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.81667890 |
| 4 | Acute encephalopathy (HP:0006846) | 3.62690094 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 3.48562901 |
| 6 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.43793036 |
| 7 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.27685967 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.26223984 |
| 9 | IgA deficiency (HP:0002720) | 3.22985144 |
| 10 | Increased intramyocellular lipid droplets (HP:0012240) | 3.21256657 |
| 11 | Gastrointestinal stroma tumor (HP:0100723) | 3.07740580 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.02186112 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.02186112 |
| 14 | Muscle fiber atrophy (HP:0100295) | 3.01146632 |
| 15 | Testicular atrophy (HP:0000029) | 3.01042989 |
| 16 | Microvesicular hepatic steatosis (HP:0001414) | 3.00863653 |
| 17 | IgM deficiency (HP:0002850) | 2.97719257 |
| 18 | Increased serum lactate (HP:0002151) | 2.93090852 |
| 19 | Type 2 muscle fiber atrophy (HP:0003554) | 2.88792102 |
| 20 | Renal Fanconi syndrome (HP:0001994) | 2.88045905 |
| 21 | Increased muscle lipid content (HP:0009058) | 2.77107507 |
| 22 | Microretrognathia (HP:0000308) | 2.75058331 |
| 23 | Abnormality of the pons (HP:0007361) | 2.72376479 |
| 24 | Hypoplasia of the pons (HP:0012110) | 2.71649430 |
| 25 | Unilateral renal agenesis (HP:0000122) | 2.70762479 |
| 26 | Increased hepatocellular lipid droplets (HP:0006565) | 2.70383152 |
| 27 | Increased CSF lactate (HP:0002490) | 2.69041505 |
| 28 | Septate vagina (HP:0001153) | 2.65951578 |
| 29 | Cleft eyelid (HP:0000625) | 2.65466801 |
| 30 | Progressive muscle weakness (HP:0003323) | 2.62294367 |
| 31 | Hepatocellular necrosis (HP:0001404) | 2.59108910 |
| 32 | Recurrent sinusitis (HP:0011108) | 2.56892482 |
| 33 | Progressive macrocephaly (HP:0004481) | 2.53350068 |
| 34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.52594458 |
| 35 | IgG deficiency (HP:0004315) | 2.52493150 |
| 36 | Hypoplasia of the uterus (HP:0000013) | 2.52097317 |
| 37 | Methylmalonic aciduria (HP:0012120) | 2.51366830 |
| 38 | Abnormal number of incisors (HP:0011064) | 2.49704492 |
| 39 | Cerebral edema (HP:0002181) | 2.49224100 |
| 40 | Lipid accumulation in hepatocytes (HP:0006561) | 2.46831488 |
| 41 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.45785004 |
| 42 | Concave nail (HP:0001598) | 2.44941772 |
| 43 | Hyperglycinemia (HP:0002154) | 2.40616032 |
| 44 | Conical tooth (HP:0000698) | 2.35628089 |
| 45 | Lactic acidosis (HP:0003128) | 2.35378771 |
| 46 | Squamous cell carcinoma (HP:0002860) | 2.32575727 |
| 47 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.31992817 |
| 48 | Cholecystitis (HP:0001082) | 2.27527545 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.27527545 |
| 50 | Acute lymphatic leukemia (HP:0006721) | 2.26011517 |
| 51 | Exercise intolerance (HP:0003546) | 2.25452360 |
| 52 | Hepatic necrosis (HP:0002605) | 2.25261817 |
| 53 | Lymphopenia (HP:0001888) | 2.24110954 |
| 54 | Redundant skin (HP:0001582) | 2.21418216 |
| 55 | Trismus (HP:0000211) | 2.21146229 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.20401652 |
| 57 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.19799027 |
| 58 | Severe visual impairment (HP:0001141) | 2.17879176 |
| 59 | Sclerocornea (HP:0000647) | 2.16941235 |
| 60 | Methylmalonic acidemia (HP:0002912) | 2.16006764 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.12218516 |
| 62 | Progressive microcephaly (HP:0000253) | 2.08994965 |
| 63 | Rough bone trabeculation (HP:0100670) | 2.03793043 |
| 64 | Exertional dyspnea (HP:0002875) | 2.00293817 |
| 65 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.99571580 |
| 66 | Hypertensive crisis (HP:0100735) | 1.99571012 |
| 67 | Congenital stationary night blindness (HP:0007642) | 1.97331721 |
| 68 | Respiratory difficulties (HP:0002880) | 1.95674052 |
| 69 | Tongue fasciculations (HP:0001308) | 1.95489481 |
| 70 | Agammaglobulinemia (HP:0004432) | 1.93873057 |
| 71 | Entropion (HP:0000621) | 1.90077799 |
| 72 | Aplastic anemia (HP:0001915) | 1.88475711 |
| 73 | Dry hair (HP:0011359) | 1.87475702 |
| 74 | Absent thumb (HP:0009777) | 1.85609424 |
| 75 | Rectovaginal fistula (HP:0000143) | 1.85184070 |
| 76 | Rectal fistula (HP:0100590) | 1.85184070 |
| 77 | Multiple enchondromatosis (HP:0005701) | 1.84979648 |
| 78 | Fibular aplasia (HP:0002990) | 1.83583352 |
| 79 | Delayed CNS myelination (HP:0002188) | 1.81543304 |
| 80 | Poor head control (HP:0002421) | 1.81105751 |
| 81 | Vaginal fistula (HP:0004320) | 1.80871195 |
| 82 | Reduced antithrombin III activity (HP:0001976) | 1.80275401 |
| 83 | Abnormality of the anterior horn cell (HP:0006802) | 1.79340882 |
| 84 | Degeneration of anterior horn cells (HP:0002398) | 1.79340882 |
| 85 | B lymphocytopenia (HP:0010976) | 1.79162597 |
| 86 | Intestinal fistula (HP:0100819) | 1.77420311 |
| 87 | Cortical visual impairment (HP:0100704) | 1.77317733 |
| 88 | Onycholysis (HP:0001806) | 1.74994485 |
| 89 | Abnormality of glycolysis (HP:0004366) | 1.72932933 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72794981 |
| 91 | Dicarboxylic aciduria (HP:0003215) | 1.72794981 |
| 92 | Pendular nystagmus (HP:0012043) | 1.71204614 |
| 93 | Type I transferrin isoform profile (HP:0003642) | 1.69463596 |
| 94 | Reticulocytopenia (HP:0001896) | 1.68719992 |
| 95 | Horseshoe kidney (HP:0000085) | 1.67766412 |
| 96 | Decreased subcutaneous fat (HP:0001002) | 1.65807021 |
| 97 | Premature skin wrinkling (HP:0100678) | 1.65630782 |
| 98 | Fatigable weakness (HP:0003473) | 1.65101902 |
| 99 | Abnormality of the neuromuscular junction (HP:0003398) | 1.65101902 |
| 100 | Difficulty climbing stairs (HP:0003551) | 1.61821285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 4.69804319 |
| 2 | VRK1 | 4.53608912 |
| 3 | TLK1 | 4.34850813 |
| 4 | BCKDK | 4.25786834 |
| 5 | MAP4K2 | 4.02157816 |
| 6 | VRK2 | 3.57035008 |
| 7 | BUB1 | 2.55690176 |
| 8 | TESK2 | 2.48970611 |
| 9 | IRAK3 | 2.36428204 |
| 10 | RPS6KA5 | 2.24291685 |
| 11 | AURKA | 2.17521006 |
| 12 | SMG1 | 2.13543113 |
| 13 | DAPK3 | 1.95654348 |
| 14 | CHEK2 | 1.91013025 |
| 15 | ARAF | 1.85450033 |
| 16 | CDK12 | 1.82752065 |
| 17 | MAP3K9 | 1.75241813 |
| 18 | PIM2 | 1.66359231 |
| 19 | MAP4K1 | 1.60455411 |
| 20 | AURKB | 1.47508208 |
| 21 | CDK8 | 1.45041950 |
| 22 | CDC7 | 1.37334344 |
| 23 | IRAK4 | 1.36065570 |
| 24 | CDK9 | 1.30662813 |
| 25 | NME2 | 1.29339186 |
| 26 | KDR | 1.18776986 |
| 27 | MST1R | 1.11710042 |
| 28 | STK4 | 1.10951715 |
| 29 | SIK1 | 1.10511079 |
| 30 | NME1 | 1.08465974 |
| 31 | ICK | 1.08191262 |
| 32 | MAP3K11 | 1.04830944 |
| 33 | GRK6 | 1.02752642 |
| 34 | CSNK1G3 | 1.02633929 |
| 35 | TESK1 | 1.01983923 |
| 36 | NEK1 | 0.99373751 |
| 37 | TAF1 | 0.97905731 |
| 38 | CDK4 | 0.94104096 |
| 39 | MAPKAPK5 | 0.92754991 |
| 40 | WNK4 | 0.91382924 |
| 41 | BRSK1 | 0.91163198 |
| 42 | MAP3K8 | 0.90954782 |
| 43 | CDK7 | 0.90323604 |
| 44 | ATR | 0.88220115 |
| 45 | CSNK1A1L | 0.87150764 |
| 46 | MAP3K10 | 0.86433945 |
| 47 | TSSK6 | 0.80507899 |
| 48 | MAPK11 | 0.80468685 |
| 49 | MAPKAPK3 | 0.79694426 |
| 50 | CAMKK2 | 0.78161565 |
| 51 | MAP2K7 | 0.77061435 |
| 52 | DAPK1 | 0.75272651 |
| 53 | STK10 | 0.74366210 |
| 54 | EIF2AK1 | 0.73502370 |
| 55 | LMTK2 | 0.73264832 |
| 56 | CCNB1 | 0.72715589 |
| 57 | BRAF | 0.72406343 |
| 58 | CHEK1 | 0.70813531 |
| 59 | PKN1 | 0.69481314 |
| 60 | EEF2K | 0.65343965 |
| 61 | IKBKB | 0.63297804 |
| 62 | BTK | 0.61399531 |
| 63 | PLK1 | 0.58099664 |
| 64 | CHUK | 0.58079022 |
| 65 | CSNK1G1 | 0.57924542 |
| 66 | SCYL2 | 0.56794344 |
| 67 | EIF2AK2 | 0.54706310 |
| 68 | TTK | 0.54297645 |
| 69 | TAOK3 | 0.52956110 |
| 70 | CSNK1G2 | 0.50567036 |
| 71 | MAP3K13 | 0.47869961 |
| 72 | ABL2 | 0.47171404 |
| 73 | CSF1R | 0.45276973 |
| 74 | PIM1 | 0.42739141 |
| 75 | PRKCI | 0.41759284 |
| 76 | TBK1 | 0.41214722 |
| 77 | SRPK1 | 0.40641767 |
| 78 | EPHA2 | 0.40003373 |
| 79 | TRIB3 | 0.39414390 |
| 80 | PRKD2 | 0.39377794 |
| 81 | AKT2 | 0.37889248 |
| 82 | CSNK2A2 | 0.36726722 |
| 83 | CAMK1D | 0.36338237 |
| 84 | PLK4 | 0.36207674 |
| 85 | HIPK2 | 0.35646670 |
| 86 | ALK | 0.34756306 |
| 87 | RAF1 | 0.34652848 |
| 88 | EIF2AK3 | 0.34192360 |
| 89 | CDK2 | 0.33531400 |
| 90 | ATM | 0.33329871 |
| 91 | PAK1 | 0.33321072 |
| 92 | TAOK2 | 0.30478319 |
| 93 | TXK | 0.27976818 |
| 94 | CDK11A | 0.27605101 |
| 95 | MKNK2 | 0.27248351 |
| 96 | TIE1 | 0.27147775 |
| 97 | CDK15 | 0.26059081 |
| 98 | CSNK2A1 | 0.25721080 |
| 99 | BRSK2 | 0.24590363 |
| 100 | DYRK2 | 0.24537608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 6.28511982 |
| 2 | Alcoholism_Homo sapiens_hsa05034 | 4.11936122 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.36710874 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.15030582 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 3.11450469 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.87191734 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.84209318 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.81594141 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.29105110 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.22229906 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.20197629 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16858586 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.12951247 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09106289 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 2.05516953 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.96677086 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.89639938 |
| 18 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.82202147 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.63534097 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.60714548 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.54455498 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.51394738 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.49519031 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48246493 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42529956 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.41731114 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.39707779 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.39015321 |
| 29 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.36933565 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36778256 |
| 31 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.30875587 |
| 32 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.30091814 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26932385 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26399284 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20471903 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.17677649 |
| 37 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15524636 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.14989506 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14877798 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12315795 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08621033 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06375992 |
| 43 | Protein export_Homo sapiens_hsa03060 | 0.98041220 |
| 44 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91163874 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.90534233 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87786476 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 0.86686346 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.79124271 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75884979 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 0.74631070 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73273849 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72936944 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71042517 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70127975 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67973861 |
| 56 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64426500 |
| 57 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59474474 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54526619 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53727198 |
| 60 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52185330 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49595619 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44780715 |
| 63 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40577424 |
| 64 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40272381 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39779047 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38474246 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38178969 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37814673 |
| 69 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.37733790 |
| 70 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37586957 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37232741 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36855872 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36598771 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35791159 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34533535 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.29278348 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28939814 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27485385 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.27427491 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26836498 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.25957930 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25546819 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.25504976 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.24687131 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.23674934 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.23048617 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.20947282 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.20546711 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20260701 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.19665756 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.19563988 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18117388 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17686972 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14338725 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.13276357 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.13013254 |
| 97 | Shigellosis_Homo sapiens_hsa05131 | 0.11174286 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.11056954 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08988488 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.08863343 |

